Efficacy and Safety of Rituximab in Refractory CIDP With or Without IgG4 Autoantibodies (RECIPE): Protocol for a Double-Blind, Randomized, Placebo-Controlled Clinical Trial

by Shimizu, Shinobu, Iijima, Masahiro, Fukami, Yuki, Tamura, Natsuko, Nakatochi, Masahiro, Ando, Masahiko, Nishi, Ryoji, Koike, Haruki, Kaida, Kenichi, Koga, Michiaki, Kanda, Takashi, Ogata, Hidenori, Kira, Jun-Ichi, Mori, Masahiro, Kuwabara, Satoshi, Katsuno, Masahisa
Published 2020-04-01